Recherche Fr menu ClientConnect
Recherche
Résultats
5 premiers résultats de la recherche Voir tous les résultats Recherche avancée
Recherches les plus fréquentes
Pages les plus visitées
    Référence: 20160727
    Date de publication: 5 septembre 2017

    Promoteur – Intermédiaire Financier

    HUVEPHARMA INTERNATIONAL BV

    Lieu

    Description

    The project consists of the construction of new manufacturing facilities, as well as financing of the promoter's research, development and innovation (RDI) activities.

    Objectifs

    The EIB loan will be supporting the capacity expansion of a mid-cap company in Bulgaria.

    Secteur(s)

    Montant BEI envisagé (montant approximatif)

    EUR 125 million

    Coût total (montant approximatif)

    EUR 212 million

    Aspects environnementaux

    The project falls under Annex II of EIA Directive 2011/92/EU (implementation of an industrial facility for the production of pharmaceutical products). Full environmental details will be assessed during the appraisal.

    Passation des marchés

    The promoter is a private company not operating in the utilities sector and is thus not covered by EU directives on procurement.

    Statut

    Signé - 22/12/2017

    Clause de non-responsabilité

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Mots-clés correspondants

    Bulgarie Industrie